Grape seed extract and resveratrol prevent 4‐nitroquinoline 1‐oxide induced oral tumorigenesis in mice by modulating AMPK activation and associated biological responses

Preventive measures against oral carcinogenesis are urgently warranted to lower the high morbidity and mortality associated with this malignancy worldwide. Here, we investigated the chemopreventive efficacy of grape seed extract (GSE) and resveratrol (Res) in 4‐nitroquinoline‐1‐oxide (4NQO)‐induced tongue tumorigenesis in C57BL/6 mice. Following 8 weeks of 4NQO exposure (100 µg/ml in drinking water), mice were fed with either control AIN‐76A diet or diet containing 0.2% GSE (w/w) or 0.25% Res (w/w) for 8 subsequent weeks, while continued on 4NQO. Upon termination of the study at 16 weeks, tongue tissues were histologically evaluated for hyperplasia, dysplasia, and papillary lesions, and then analyzed for molecular targets by immunohistochemistry. GSE and Res feeding for 8 weeks, moderately decreased the incidence, but significantly prevented the multiplicity and severity of 4NQO‐induced preneoplastic and neoplastic lesions, without any apparent toxicity. In tongue tissues, both 4NQO + GSE and 4NQO + Res treatment correlated with a decreased proliferation (BrdU labeling index) but increased apoptotic death (TUNEL‐positive cells) as compared to the 4NQO group. Furthermore, tongue tissues from both the 4NQO + GSE and 4NQO + Res groups showed an increase in activated metabolic regulator phospho‐AMPK (Thr172) and decreased autophagy flux marker p62. Together, these findings suggest that GSE and Res could effectively prevent 4NQO‐induced oral tumorigenesis through modulating AMPK activation, and thereby, inhibiting proliferation and inducing apoptosis and autophagy, as mechanisms of their efficacy. © 2013 Wiley Periodicals, Inc.

[1]  D. Ribeiro,et al.  Polyphenols as a chemopreventive agent in oral carcinogenesis: putative mechanisms of action using in-vitro and in-vivo test systems , 2013, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[2]  A. Jemal,et al.  Cancer statistics, 2013 , 2013, CA: a cancer journal for clinicians.

[3]  M. Tsai,et al.  Pterostilbene, a natural analogue of resveratrol, potently inhibits 7,12-dimethylbenz[a]anthracene (DMBA)/12-O-tetradecanoylphorbol-13-acetate (TPA)-induced mouse skin carcinogenesis. , 2012, Food & function.

[4]  E. Selimoğlu,et al.  The effect of resveratrol on the prevention of cisplatin ototoxicity , 2012, European Archives of Oto-Rhino-Laryngology.

[5]  M. Chou,et al.  Impairment of tumor-initiating stem-like property and reversal of epithelial-mesenchymal transdifferentiation in head and neck cancer by resveratrol treatment. , 2012, Molecular nutrition & food research.

[6]  H. Rikiishi Autophagic action of new targeting agents in head and neck oncology , 2012, Cancer biology & therapy.

[7]  R. Agarwal,et al.  Generation of reactive oxygen species by grape seed extract causes irreparable DNA damage leading to G2/M arrest and apoptosis selectively in head and neck squamous cell carcinoma cells. , 2012, Carcinogenesis.

[8]  J. S. Gutkind,et al.  Metformin Prevents the Development of Oral Squamous Cell Carcinomas from Carcinogen-Induced Premalignant Lesions , 2012, Cancer Prevention Research.

[9]  J. L. Lacau St Guily,et al.  HPV and head and neck cancer. , 2012, European annals of otorhinolaryngology, head and neck diseases.

[10]  E. Rosenthal,et al.  Grape Seed Proanthocyanidins Inhibit the Invasiveness of Human HNSCC Cells by Targeting EGFR and Reversing the Epithelial-To-Mesenchymal Transition , 2012, PloS one.

[11]  D. Parkin,et al.  16. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010 , 2011, British Journal of Cancer.

[12]  R. Peto,et al.  The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010 , 2011, British Journal of Cancer.

[13]  R. Mehrotra,et al.  Exciting new advances in oral cancer diagnosis: avenues to early detection , 2011, Head & neck oncology.

[14]  R. Agarwal,et al.  Resveratrol Selectively Induces DNA Damage, Independent of Smad4 Expression, in Its Efficacy against Human Head and Neck Squamous Cell Carcinoma , 2011, Clinical Cancer Research.

[15]  C. Van Waes,et al.  EGFR–PI3K–AKT–mTOR signaling in head and neck squamous cell carcinomas: attractive targets for molecular-oriented therapy , 2011, Expert opinion on therapeutic targets.

[16]  K. Coombes,et al.  Proteomic Profiling Identifies Pathways Dysregulated in Non-small Cell Lung Cancer and an Inverse Association of AMPK and Adhesion Pathways with Recurrence , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[17]  S. Advani,et al.  Targeting mTOR pathway: A new concept in cancer therapy , 2010, Indian Journal of Medical and Paediatric Oncology.

[18]  M. Loda,et al.  Prognostic significance of AMP-activated protein kinase expression and modifying effect of MAPK3/1 in colorectal cancer , 2010, British Journal of Cancer.

[19]  Neeraj Singhal,et al.  Steady-State Pharmacokinetics and Tolerability of Trans-Resveratrol 2000mg Twice Daily with Food, Quercetin and Alcohol (Ethanol) in Healthy Human Subjects , 2010, Clinical pharmacokinetics.

[20]  D. Grandér,et al.  Autophagy: cancer therapy's friend or foe? , 2010, Future medicinal chemistry.

[21]  A. García-García,et al.  Genetic and molecular alterations associated with oral squamous cell cancer (Review). , 2009, Oncology reports.

[22]  Martin Görner,et al.  HPV & head and neck cancer: a descriptive update , 2009, Head & neck oncology.

[23]  R. Agarwal,et al.  Anticancer and cancer chemopreventive potential of grape seed extract and other grape-based products. , 2009, The Journal of nutrition.

[24]  R. Shaw,et al.  The LKB1–AMPK pathway: metabolism and growth control in tumour suppression , 2009, Nature Reviews Cancer.

[25]  A. Saad,et al.  Protective effect of grape seed proanthocyanidin extract against oxidative stress induced by cisplatin in rats. , 2009, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[26]  R. Hasina,et al.  ABT-510 Is an Effective Chemopreventive Agent in the Mouse 4-Nitroquinoline 1-Oxide Model of Oral Carcinogenesis , 2009, Cancer Prevention Research.

[27]  V. Patel,et al.  Targeting Mammalian Target of Rapamycin by Rapamycin Prevents Tumor Progression in an Oral-Specific Chemical Carcinogenesis Model , 2009, Cancer Prevention Research.

[28]  K. Wong Oral-Specific Chemical Carcinogenesis in Mice: An Exciting Model for Cancer Prevention and Therapy , 2009, Cancer Prevention Research.

[29]  D. Carling,et al.  The regulation of AMP-activated protein kinase by upstream kinases , 2008, International Journal of Obesity.

[30]  J. Milner,et al.  Diet, Autophagy, and Cancer: A Review , 2008, Cancer Epidemiology Biomarkers & Prevention.

[31]  R. Agarwal,et al.  Chemopreventive effects of silymarin and silibinin on N-butyl-N-(4-hydroxybutyl) nitrosamine–induced urinary bladder carcinogenesis in male ICR mice , 2007, Molecular Cancer Therapeutics.

[32]  H. A. Weber,et al.  Comparison of proanthocyanidins in commercial antioxidants: grape seed and pine bark extracts. , 2007, Journal of agricultural and food chemistry.

[33]  P. Codogno,et al.  AMP-Activated Protein Kinase and Autophagy , 2007, Autophagy.

[34]  Deepak Kanojia,et al.  4-nitroquinoline-1-oxide induced experimental oral carcinogenesis. , 2006, Oral oncology.

[35]  A. Dennison,et al.  Pilot Study of Oral Silibinin, a Putative Chemopreventive Agent, in Colorectal Cancer Patients: Silibinin Levels in Plasma, Colorectum, and Liver and Their Pharmacodynamic Consequences , 2006, Clinical Cancer Research.

[36]  I. Angelillo,et al.  Association between fruit and vegetable consumption and oral cancer: a meta-analysis of observational studies. , 2006, The American journal of clinical nutrition.

[37]  L. Thompson,et al.  World Health Organization Classification of Tumours: Pathology and Genetics of Head and Neck Tumours , 2006, Ear, nose, & throat journal.

[38]  Jacinto J. Regalado,et al.  Molecular predictors of clinical outcome in patients with head and neck squamous cell carcinoma , 2005, International journal of experimental pathology.

[39]  E. Sausville,et al.  Mammalian target of rapamycin, a molecular target in squamous cell carcinomas of the head and neck. , 2005, Cancer research.

[40]  B. Aggarwal,et al.  Role of chemopreventive agents in cancer therapy. , 2004, Cancer letters.

[41]  N. Seeram,et al.  Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. , 2004, Anticancer research.

[42]  S. Tickoo,et al.  Oral Cavity and Esophageal Carcinogenesis Modeled in Carcinogen-Treated Mice , 2004, Clinical Cancer Research.

[43]  M. Kikuchi,et al.  Procyanidin B1 Is Detected in Human Serum after Intake of Proanthocyanidin-rich Grape Seed Extract , 2003, Bioscience, biotechnology, and biochemistry.

[44]  Takuji Tanaka,et al.  Dietary silymarin suppresses 4-nitroquinoline 1-oxide-induced tongue carcinogenesis in male F344 rats. , 2002, Carcinogenesis.

[45]  M. Kikuchi,et al.  Safety evaluation of proanthocyanidin-rich extract from grape seeds. , 2002, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[46]  D. Bagchi,et al.  Acute and long-term safety evaluation of a novel IH636 grape seed proanthocyanidin extract. , 2001, Research communications in molecular pathology and pharmacology.

[47]  A. Hara,et al.  Chemopreventive effect of dietary flavonoid morin on chemically induced rat tongue carcinogenesis , 1999, International journal of cancer.

[48]  P. Boyle,et al.  Alcohol, tobacco, diet and the risk of oral cancer: a pooled analysis of three case-control studies. , 1995, European journal of cancer. Part B, Oral oncology.

[49]  J. M. Nauta,et al.  Comparison of epithelial dysplasia--the 4NQO rat palate model and human oral mucosa. , 1995, International journal of oral and maxillofacial surgery.

[50]  A. Nishikawa,et al.  Inhibitory effects of non-steroidal anti-inflammatory drugs, piroxicam and indomethacin on 4-nitroquinoline 1-oxide-induced tongue carcinogenesis in male ACI/N rats. , 1989, Cancer letters.

[51]  P. Auberger,et al.  When autophagy meets cancer through p62/SQSTM1. , 2012, American journal of cancer research.

[52]  G. Rajesh,et al.  Retrospective study on risk habits among oral cancer patients in Karnataka Cancer Therapy and Research Institute, Hubli, India. , 2011, Asian Pacific journal of cancer prevention : APJCP.

[53]  A. Mueller,et al.  Head and neck cancer in Germany: a site-specific analysis of survival of the Thuringian cancer registration database , 2009, Journal of Cancer Research and Clinical Oncology.

[54]  A. Gruzman,et al.  Adenosine Monophosphate-Activated Protein Kinase (AMPK) as a New Target for Antidiabetic Drugs: A Review on Metabolic, Pharmacological and Chemical Considerations. , 2009, The review of diabetic studies : RDS.

[55]  D. Brachman,et al.  Molecular biology of head and neck cancer. , 1994, Seminars in oncology.

[56]  N. Dubrawsky Cancer statistics , 1989, CA: a cancer journal for clinicians.